Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

Poly-D-Leucine

    • Product Name Poly-D-Leucine
    • Alias PDL
    • Einecs 309-430-1
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    980427

    Chemical Name Poly-D-Leucine
    Synonyms Poly(D-leucine)
    Molecular Formula (C6H11NO)n
    Cas Number 25309-55-1
    Appearance White to off-white powder
    Solubility Insoluble in water, soluble in some organic solvents
    Molecular Weight Variable (polymer)
    Optical Activity Levorotatory (D-enantiomer)
    Storage Temperature 2-8°C
    Purity Typically >95%
    Usage Biochemical research, cell adhesion studies
    Polymer Type Homopolymer of D-leucine
    Biodegradability Slow, due to D-amino acid configuration
    Stability Stable under recommended storage conditions
    Source Synthetic

    As an accredited Poly-D-Leucine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Poly-D-Leucine, 5 grams, is supplied in a sealed amber glass vial with tamper-evident cap, labeled with safety and handling instructions.
    Shipping Poly-D-Leucine is shipped in tightly sealed containers to prevent contamination and moisture exposure. It is packaged according to safety and regulatory standards, typically at ambient temperature unless otherwise required. Shipping includes appropriate labeling for laboratory chemicals, ensuring safe and secure delivery for research or industrial applications.
    Storage Poly-D-Leucine should be stored in a cool, dry place, protected from light and moisture. Keep it tightly sealed in its original container, preferably at 2–8°C (refrigerated) to maintain stability. Avoid repeated freeze-thaw cycles and exposure to air. For long-term storage, aliquot and store at -20°C. Ensure proper labeling and keep away from incompatible substances.
    Application of Poly-D-Leucine

    Applications of Poly-D-Leucine in Industrial Manufacturing

    Poly-D-Leucine serves as a specialty amino acid polymer with defined stereochemistry, supporting advanced process needs across biopharmaceutical, biotechnology, diagnostics, functional materials, and specialty coatings industries. As the direct manufacturer, we supply industrial-scale batches with batch-level recordkeeping for regulated and performance-driven markets.

    1. Biopharmaceutical Peptide Synthesis

    Biologic manufacturers use Poly-D-Leucine as a key building block in solid-phase peptide synthesis, particularly for preparing peptide APIs with enhanced resistance to enzymatic degradation. Its D-isomer configuration enables the creation of peptides used in metabolic, oncological, and infectious disease applications where prolonged bioactivity and specific conformation are critical. Scale-up batches require traceability and documentation for regulatory submissions and GMP compliance.

    Industry compliance standards

    • ICH Q7: Good Manufacturing Practice for Active Pharmaceutical Ingredients
    • USP General Chapter <1047> for Peptide APIs
    • 21 CFR Part 211: US FDA cGMPs for Finished Pharmaceuticals
    • EP Monographs for Synthetic Peptides

    Typical usage ratio

    • 1–10 mol% as substituted residue in peptide chain; adjusted based on peptide length, desired protease resistance, and downstream therapeutic use

    Downstream process integration

    • Introduced during resin-based solid-phase peptide elongation, often at N-terminal or internal positions; monitored by HPLC for batch consistency; removal of unincorporated monomers prior to cleavage and purification

    Final product types

    • Therapeutic peptides (e.g., metabolic inhibitors, anti-infectives)
    • Preclinical peptide standards
    • Peptide vaccines
    • Diagnostic peptide reagents

    2. Cell Culture and Tissue Engineering Matrices

    Manufacturers of substrates for cell culture utilize Poly-D-Leucine due to its reduced susceptibility to enzymatic breakdown and its influence on cellular adhesion in certain stem cell lines. Its incorporation enhances the durability of hydrogel and scaffold systems, supporting prolonged in vitro cell proliferation for research, preclinical, and regulated cell therapy applications.

    Industry compliance standards

    • ISO 10993-1: Biological Evaluation of Medical Devices
    • USP Class VI Biological Reactivity Tests
    • ISO 13485: Quality Management for Medical Devices

    Typical usage ratio

    • 0.05–1% w/w relative to base matrix (alginate, PEG, or collagen), based on scaffold density and target cell type requirements

    Downstream process integration

    • Added during hydrogel precursor formulation stage; co-dissolved or blended prior to cross-linking; concentration validated through mechanical and surface property assays

    Final product types

    • 3D cell culture matrices
    • Tissue engineering scaffolds
    • Cell therapy manufacturing supports
    • Coated multiwell assay plates

    3. Diagnostic Assay Surface Coatings

    Producers of immunoassays and biosensor devices integrate Poly-D-Leucine as a surface modifier to minimize non-specific protein adsorption and enhance signal stability. Its D-form limits proteolytic degradation on critical assay surfaces, extending shelf life for diagnostic reagents and enhancing reproducibility in clinical laboratory use.

    Industry compliance standards

    • ISO 13485: Medical Devices—Quality Management Systems
    • CLSI EP12-A2: Immunoassay Performance Criteria
    • 21 CFR 820: US FDA QSR for Medical Devices

    Typical usage ratio

    • 0.01–0.1 mg/cm² of coated surface area, adjusted to match detection limit requirements and assay substrate compatibility

    Downstream process integration

    • Coating applied via dipping, spraying, or microdispensing onto assay wells or sensor chips during production line; cross-linking or drying phases tailored per application

    Final product types

    • ELISA plate surfaces
    • Point-of-care test strips
    • Microarray slides
    • Biochip sensors

    4. Chiral Stationary Phases for Chromatography

    Manufacturers of analytical and preparative chromatography columns employ Poly-D-Leucine as a component in producing chiral stationary phases for enantiomeric separations. Its defined stereochemistry enables the resolution of optical isomers, benefitting pharmaceutical quality control and research labs that require high selectivity for D/L- and R/S-compounds.

    Industry compliance standards

    • USP General Chapter <621> Chromatography
    • ICH Q2(R1): Validation of Analytical Procedures
    • ISO/IEC 17025:2017 Testing Laboratory Accreditation (where in-house columns produced)

    Typical usage ratio

    • Typically 5–20% w/w in polymer matrix for silica or polymeric bead coatings; adjusted based on target analyte and required resolution

    Downstream process integration

    • Polymer introduced during co-condensation or surface-grafting onto chromatographic supports; validated via batch column testing for reproducibility

    Final product types

    • High-performance liquid chromatography (HPLC) chiral columns
    • Preparative chromatography media
    • Analytical test kits for enantiomeric purity
    • Lab-scale purification products

    5. Functional Coatings for Biomedical Implants

    Medical implant coating manufacturers add Poly-D-Leucine to composite coatings to engineer surfaces with modulated biological interactions. Its D-configuration impacts protein fouling and cell adhesion, which is crucial for temporary implants, controlled degradation, and experimental biointerfaces. Process development must meet stringent trace metal and bioburden specifications.

    Industry compliance standards

    • ISO 10993-18: Chemical Characterization of Medical Device Materials
    • EU MDR 2017/745 for Implantable Devices
    • ASTM F2459: Extractable Residues Testing

    Typical usage ratio

    • 0.1–2% w/w in coating formulation, depending on device surface area, target degradation rate, and therapeutic mechanism

    Downstream process integration

    • Dispersed in solvent for dip-coating or spray-coating onto device surfaces; cross-linking or blending with bioresorbable polymers during final device finishing

    Final product types

    • Bioresorbable stent coatings
    • Temporary fixation device surfaces
    • Biointerface-modulated implant components
    • Test articles for biocompatibility study

    6. Specialty Additive in Polymer-Based Drug Delivery

    Producers of controlled-release pharmaceutical formulations use Poly-D-Leucine as a minor additive in block copolymer systems, micelles, and nanoparticles. It modulates interaction kinetics and the release profile, specifically for delivery of peptides or hydrophobic drug payloads. Documentation and release testing must match regulated final dosage form criteria.

    Industry compliance standards

    • ICH Q6A: Specifications—Test Procedures for New Drug Substances
    • USP <795> and <1207> for Pharmaceutical Compounding and Packaging
    • European Pharmacopoeia 3.2.2: Pharmaceutical Additives

    Typical usage ratio

    • 0.5–4% by polymer weight, optimized to achieve desired release kinetics and maintain stability through shelf life

    Downstream process integration

    • Blended with base polymer before nanoparticle or copolymer assembly; dispersion monitored using particle-size and release profile assays

    Final product types

    • Injectable depot drug delivery systems
    • Oral sustained-release capsules
    • Nanoparticle and micelle suspensions
    • Transdermal patch matrices
    Free Quote

    Competitive Poly-D-Leucine prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Poly-D-Leucine: A Closer Look From a Manufacturer’s Workbench

    Introduction to Poly-D-Leucine

    In the chemical manufacturing business, certain products quietly become indispensable tools for researchers and innovators. Poly-D-Leucine finds itself among these trusted resources, especially throughout peptide science and the materials field. As a team that puts its hands directly into synthesis and production, we have seen interest rising steadily around Poly-D-Leucine, not just for its structural role, but for its unique biological features.

    Poly-D-Leucine stands apart from its L-isomer cousin through a simple, yet powerful difference: the handedness of its amino acids. This chirality shift from the naturally prevalent L-forms changes both its chemical behavior and the way living systems interact with it. In our production lines, that means careful selection and control of raw materials, keeping a constant eye on enantiomeric purity, because even minor variations can shift how the polymer behaves in downstream applications.

    Specifications and Models—What Matters In Practice

    We produce Poly-D-Leucine mainly as a homopolymer, with chain lengths from a few to hundreds of residues, depending on what end users require. Molecular weights range from a few kilodaltons up to levels suitable for more robust material testing. Our most requested variations are in powder form, with guaranteed moisture control, as water absorption plays a role in its final physical state.

    From our experience on the production floor, controlling polymerization conditions means everything. Chain length impacts solubility, mechanical properties, and how it interacts with biological systems. Rather than focus on a fixed average, we pay close attention to the distribution—the “polydispersity index”—since researchers need consistent, predictable performance when moving from batch to batch. We've found that even minor deviations in polymerization temperature or catalyst purity will show up later as unexpected experimental results, so our staff runs multiple checkpoints throughout each lot.

    Uses Shaped by the Laboratory and Industry

    Poly-D-Leucine draws attention in a variety of research disciplines. Scientists often turn to it for making model membranes, exploring enzyme resistance, and building peptide-based materials. Its D-amino backbone means that the polymer resists enzymatic degradation far better than its L-isomer. This feature alone has driven much of its use in tissue engineering studies and controlled drug release systems. The need for stability in biological environments is something our customers bring up often—they run long experiments, test biomaterials in harsh conditions, and appreciate knowing their inputs will last under proteolytic attack.

    Beyond the biology-focused arenas, Poly-D-Leucine has provided surface coatings that modify cell adhesion and influence protein adsorption. It doesn’t melt down or break up easily, even when left in solutions teeming with enzymes that would rapidly digest ordinary peptides. On our end, we regularly analyze the resistance of our lots to proteases, confirming that each shipment meets the promise of high durability. Researchers have used Poly-D-Leucine coatings on glassware, microplates, and even semiconductor materials to build biosensors and test how cells behave on specialized surfaces.

    More recently, those working to design non-natural or “mirror-image” biological systems have found Poly-D-Leucine vital for creating reference controls and functional scaffolds. The way the D-chirality flips molecular orientation changes how peptides assemble, how cells attach, and how the immune system reacts. For our part, we track advances in these fast-moving fields, making sure our synthesis routes can deliver new chain lengths and purities as scientists keep pushing boundaries.

    What Sets Poly-D-Leucine Apart

    Plenty of researchers today talk about polyamino acids and peptide polymers, but not all are created equal. L-polymers attract the most historic interest, partly because they’re found in living creatures. The D-form shifts dynamics entirely. Cells and enzymes designed to handle L-peptides often don’t recognize or degrade D-peptides. This trait makes Poly-D-Leucine a top pick whenever resistance to natural breakdown is a priority. From work in our application labs, we know that a simple switch from L to D creates marked differences in outcomes, sometimes opening doors that classic peptides leave closed.

    Our technical conversations usually land on the topic of stereochemistry—not the most glamorous subject, but a critical one. The wrong form slows down research, adds costs, and can sink entire projects built around peptide materials. By sticking with high-performance synthetic pathways and verifying stereopurity batch after batch, we’ve enabled university and industrial teams to depend on reliable, repeatable results through years of collaboration.

    Another practical difference comes from solubility and self-assembly. Many poly-L-amino acids exhibit strong tendencies to self-assemble into fibers or sheets, driven by hydrogen bonding common in natural proteins. The D-forms don’t always line up the same way. Poly-D-Leucine may dissolve more readily or yield different nanostructures. With many customers aiming to study how chirality affects cell interaction or nanomaterial behavior, this variability becomes an advantage, not a drawback—if the material is consistent and documented.

    From Manufacturing Floor To Research Bench

    Real insight into Poly-D-Leucine’s quality comes not from flashy paperwork but from daily production experience. We have learned hard lessons on what it takes to create polymers that match users’ high expectations—issues like temperature swings, uneven agitation, or changes in monomer lots can ruin a batch. Automation assists, but there’s no replacement for hands-on know-how. Every new run starts with raw material verification, moves through tightly monitored synthesis, and ends with exhaustive purity analysis.

    We make it a point to maintain detailed records on every lot. Our logs cover trace impurities, water content, average molecular weight, and optical rotation to confirm D-configuration. Customers who value reproducibility appreciate this level of detail, since even a single polymer chain of the wrong length or chirality can throw off sensitive cell studies.

    Supporting Reliable Research—Why Details Don’t Slip Through

    Because Poly-D-Leucine acts as a workhorse in so many evolving fields, our team receives direct feedback on performance, especially in biological settings. Failures rarely come from catastrophic contamination, rather from tiny inconsistencies in synthesis. A batch that dissolves unevenly, or shows atypical mechanical behavior, can derail months of planning on the user end.

    Handling those risks takes more than just physical safeguards or theoretical chemistry. Over years, we’ve learned to double-check solvent grades, monitor polymerization time, and fine-tune purification steps for each customer order. Whether someone studies neurobiology or builds biosensors, researchers share the same concern: will the Poly-D-Leucine tomorrow behave like last year’s? Our commitment lies not just in shipping out high-purity lots, but in offering traceable, verifiable records with every order.

    Advancing Poly-D-Leucine Applications: Real Challenges, Tangible Solutions

    Research findings don’t stand still. Scientists regularly send us questions about testing new molecular designs, scaling up for animal studies, or shifting to clinical-grade protocols. Those questions don’t always have neat answers in standard protocols. For example, scientists experiment by grafting Poly-D-Leucine onto hydrogels or embedding it into drug carriers, seeking to harness its non-degradable nature.

    From our seat, the main challenge in these applications lies in building molecules that behave reliably in complex biological environments. Purity, chain-length uniformity, and avoidance of residual reagents top the list of concerns. Our solution has centered on thorough pre- and post-synthesis cleaning, including repeated precipitation and chromatography to strip away unreacted monomer or side products. We maintain separate lines and cleaning regimens for each chiral polymer to eliminate cross-contamination—a step that costs time and resources but pays back in user trust.

    Matching research-grade production with industrial-scale processes brings its own hurdles. Early on, we faced bottlenecks in scaling the coupling reactions needed for longer Poly-D-Leucine chains. We tried batch reactors, switched to continuous processes, and ended up with semi-batch systems balancing cost and consistency. Technicians keep a close eye on viscosity changes, since chain elongation impacts mixing efficiency, solvent access, and purification. These lessons feed back into how we advise users—if someone moves from milligram-scale up to multi-gram syntheses, we warn them to expect shifts in reaction timings and product isolation.

    Troubleshooting and Technical Support

    Product consistency only matters if customers can actually use the product well. The composition, purity, and physical form of Poly-D-Leucine affect how it behaves in any given experiment. Sometimes a researcher expects rapid dissolution and instead gets slow dispersal, or finds the polymer precipitating where it’s meant to remain soluble. In addressing these calls, our technical team coordinates with the production staff to check solubility records, batch process logs, and offer recommendations—from adjusting solvent choices to optimizing heating cycles.

    We go beyond surface technical support with training and documentation. New customers often benefit from tips on dissolving higher-molecular-weight forms or filtering for micron-level clarity. Through comparison with our in-house reference standards, we can reveal if chain-length distribution is the issue, or if storage conditions at the lab have caused subtle changes. In some cases, troubleshooting has revealed valuable new use cases: higher density Poly-D-Leucine solutions provide robust cell-resistant coatings, while shorter chains have boosted stability in sensitive optical sensors.

    Comparing Poly-D-Leucine to Other Polyamino Acids

    To put Poly-D-Leucine side-by-side with other polyamino acids is to highlight both what distinguishes it and what makes it a compatible companion material. While Poly-L-Leucine establishes itself as a familiar reference in synthetic biology, Poly-D-Leucine capably fills roles where biological resistance or altered molecular recognition is needed. Poly-L-Lysine, for instance, promotes cell adhesion when coating cultureware. Poly-D-Leucine does the opposite, making it valuable for experiments that require minimal cell interaction or contamination.

    Other polyamino acids, like Poly-D-Glutamic Acid or Poly-L-Arginine, also bring signature properties. Acidic polyamino acids attract usage in materials science for their high negative charge, while basic versions draw attention for their gene delivery performance. Poly-D-Leucine sits in the hydrophobic spectrum, encouraging aggregation and imparting different physical properties. These differences might sound subtle, but in hands-on laboratory work, such chemical details dictate the trajectory of results.

    Another point of contrast comes from how the polymers survive real-world lab handling. Some users have found that L-isomers degrade in solutions or during sterilization, especially under heat or in challenging pH environments. Poly-D-Leucine resists typical degradation routes, supporting more robust experimental designs, and opening opportunities to study biological responses to “unnatural” peptides.

    Looking Ahead: Where Poly-D-Leucine Leads

    Poly-D-Leucine remains a niche product, but persistent demand from forward-looking scientists sustains its place in our catalog. Increasingly, the focus falls on new uses in regenerative medicine, adaptive materials, and even antiaging interventions. Researchers have shared their findings showing that D-amino acid polymers, Poly-D-Leucine among them, may one day support implantable medical devices or function as stable carriers for complex drug molecules.

    With origins in well-established peptide synthesis chemistry, the future for Poly-D-Leucine hinges on keeping quality high while supporting expanding needs. Producing consistent batches isn’t glamorous, but as a manufacturer, it aligns with building a record of reliability and expertise. Innovations in reaction automation, purification, and real-time quality monitoring can shorten lead times and raise reliability. For us, investing in these areas means more than simple sales—it keeps our materials on the front lines of scientific progress.

    Conclusion

    Drawing on years spent troubleshooting, refining, and fulfilling custom production runs, we see Poly-D-Leucine as more than a product code in a list. Real-world manufacturing experience shapes our approach and lets us support bench scientists and industrial developers with equal confidence. Poly-D-Leucine’s place in research and development continues to grow as scientists uncover new ways to leverage its bio-resistance and unique structure. The road ahead offers new technical challenges, but our commitment remains based on direct industry experience, attention to detail, and a willingness to adapt as science itself moves forward.